Document Detail


Prevention or reversal of atherosclerosis: review of current evidence.
MedLine Citation:
PMID:  2650523     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Treatment with lipid-reducing agents is associated with reduced morbidity and mortality from coronary heart disease. Such treatment appears to work at the level of the atherosclerotic lesion, causing stabilization, slowed progression and, in some cases, regression of lesions. Morbidity and mortality studies of cholestyramine and gemfibrozil treatment have shown that a reduction of lipid levels was associated with reduced mortality from coronary heart disease; niacin treatment has been shown to have long-term effects on reducing cardiovascular mortality. Angiographic studies have documented that beneficial effects of treatment with lipid-reducing agents and intensive computer-assisted diet counseling occur at the level of the coronary atherosclerotic lesion.
Authors:
D H Blankenhorn
Related Documents :
17616023 - The epidemiological and clinical characteristics of patients admitted for coronary angi...
15282433 - Inflammation and atherosclerosis in acute coronary syndromes.
7754943 - Risk factors for the development of recurrent atrial fibrillation: role of pacing and c...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The American journal of cardiology     Volume:  63     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1989 May 
Date Detail:
Created Date:  1989-05-24     Completed Date:  1989-05-24     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  38H-41H     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiography
Antilipemic Agents / therapeutic use*
Coronary Artery Disease / epidemiology,  mortality,  prevention & control*
Humans
Chemical
Reg. No./Substance:
0/Antilipemic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diabetes mellitus and hypertension in the elderly: concomitant hyperlipidemia and coronary heart dis...
Next Document:  Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease i...